T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: Structural requirements and clinical implications

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 1894-1901

  Kozovska, Milena ^a,b   Zang, Ying C Q ^a,b   Aebischer, Iwan ^a,b   Lnu, Savita ^a,b   Rivera, Victor M ^a   Crowe, Paul D ^c   Boehme, Stefen A ^c   Zhang, Jingwu Z ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Altered peptide ligand; Autoimmunity; Multiple sclerosis; Myelin basic protein; TCR

Indexed keywords

ALANINE; CYTOKINE; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALANINE; CELLS, CULTURED; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; INTERLEUKIN-10; LYSINE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PAPILLOMAVIRIDAE; PEPTIDE FRAGMENTS; PEPTIDES; PHENYLALANINE; RECEPTORS, ANTIGEN, T-CELL; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0031841212     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1894::AID-IMMU1894>3.0.CO;2-W     Document Type: Article

References (14)

1. Stinissen, P., Raus, J. and Zhang, J., Autoimmune mechanism and new therapeutic strategies in multiple sclerosis. Crit. Rev. Immunol. 1997. 17: 33-75.
2. Zhang, J., Markovic, S., Lacet, B., Raus, J., Weiner, H. L. and Hafler, D. A., Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 1994. 179: 973-984.
3. Vandevyver, C., Mertens, N., van den Elsen, P., Raus, J. and Zhang, J., Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 1995. 25: 958-968.
4. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L. and Hafler, D. A., T cell recognition of an immunodominant MBP epitope in multiple sclerosis. Nature 1990. 346: 183-187.
5. Pette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A., Epplen, J. T., Kappos, L. and Wekerle, H., Myelin autoreactivity in multiple sclerosis: recognition of MBP in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 1990. 87: 7968-7972.
6. Zhang, J., Medaer, R., Chin, Y., van den Berg-Loonen, E. and Raus, J., Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 1992. 32: 330-338.
7. Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D. and Adorini, L., Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cell from multiple sclerosis patients. J. Clin. Invest. 1993. 91: 616-628.
8. Allen, P. M., Matsueda, G. R., Evans, R. J., Dunbar, J. B., Marshall, G. R. and Unanue, E. R., Identification of the T cell and Ia contact residues of a T cell antigenic epitope. Nature 1987. 327: 713-715.
9. Racioppi, L., Ronchese, F., Matis, L. A. and Germain, R. N., Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent signaling. J. Exp. Med. 1993. 177: 1047-1060.
10. Brocke, S., Gijels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D. and Steinman, L., Treatment of experimental autoimmune encephalomyelitis with a peptide analogue of myelin basic protein. Nature 1996. 379: 343-346.
11. Wucherpfennig, K. and Strominger, J., Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995. 80: 695-705.
12. Wucherpfennig, K., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L. and Hafler, D. A., Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human cell clones. J. Exp. Med. 1994. 179: 279-290.
13. Hemmer, B., Fleckenstein, B. T., Vergelli, M., Jung, G., McFarland, H., Martin, R. and Wiesmuller, K. H., Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 1996. 185: 1651-1659.
14. Deibler, G. E., Martenson, R. E. and Kies, M. W., Large scale preparation of myelin basic protein of several mammalian species. Prep. Biochem. 1972. 2: 139-165.